Tag: Dan Starck
Executive changes: Owens & Minor, Inogen
April 22, 2024HME News Staff
RICHMOND, Va. – Owens & Minor has announced that Dan Starck, executive vice president of business excellence, has informed the company that he is retiring on May 17, 2024.
Richmond, Va.-based OM made the announcement in a Form 8-K filed with the U.S. Securities and Exchange Commission on April 16.
Starck became part of OM’s executive leadership team when the company acquired Apria Healthcare in 2022 for about $1.45 billion, expanding its Patient Direct business unit.
In...
CQRC leads way on oxygen reform
April 12, 2024Theresa Flaherty, Managing Editor
WASHINGTON – The fact that the HME industry, physician groups and patient groups are all in alignment on what needs to be done to fix the Medicare oxygen benefit should help to propel a new bill forward, says Dan Starck, interim chair of the Council for Quality Respiratory Care.
The Supplemental Oxygen Access Reform (SOAR) Act, introduced in late February in the Senate and in late March in the House of Representatives, has support from heavy hitters like the American Lung Association,...
Owens & Minor: ‘We’re not waiting’
March 3, 2023Theresa Flaherty, Managing Editor
RICHMOND, Va. – Owens & Minor has kicked off an ambitious, companywide program to “right size” the business in the face of new market conditions, said company execs on a call to discuss its fourth quarter and full year 2022 earnings.
The move is expected to drive $30 million of adjusted operating income in 2023 and provide between $250 million and $400 million of working capital benefits by 2025, said Edward Pesicka, president and CEO.
“Look, we're not...
CQRC calls for clear post-PHE transition
February 27, 2023Theresa Flaherty, Managing Editor
WASHINGTON – With a “massive” number of patients starting on home respiratory therapy during the COVID-19 pandemic, the Council for Quality Respiratory Care is renewing its call for a transition period to ensure those patients don’t lose access when the public health emergency ends on May 11, says the Council for Quality Respiratory Care.
While providers are ready to move past the pandemic, much of that readiness depends on any guidance CMS provides, especially for...
Apria grows sleep biz, despite drag on supply
November 5, 2021Theresa Flaherty, Managing Editor
INDIANAPOLIS – As Apria looks to the end of the year, the availability of CPAP devices is a “wild card,” says CEO Dan Starck.
“We saw a sustained increase in incoming volume through Q3 and continue to see it in October and November,” he said on a call to discuss the company’s most recent financial results. “If we could get our hands on more equipment, we’d have much more growth in the quarter from a sleep standpoint.”
Apria’s...
Apria delivers ‘solid’ quarter
November 4, 2021HME News Staff
INDIANAPOLIS – Apria Healthcare reported net revenue of $287.2 million for the third quarter of 2021, up 3.8% compared to $276.8 million one year ago.
For the quarter, net income was $22.8 million, up 300.1% from $5.7 million; adjusted EBITDA was $61 million and adjusted EBITDA less patient equipment capex of $38.9 million.
“We continue to see strong new patient volume for oxygen driven by the Delta variant which we expect to remain at elevated levels compared to historical run...
Starck reflects on pandemic
August 31, 2021Theresa Flaherty, Managing Editor
As the COVID-19 pandemic began to take hold in early 2020, Apria, like most other companies, had no idea what to expect, says CEO Dan Starck.
“It’s been an interesting 17 months,” he said. “We’re still observing all things related to good practice, PPE, contactless delivery. We’re contemplating bringing people back at some point, but that’s the exception right now.”
Starck spoke with HME News recently, reflecting on lessons learned...
Apria intensifies focus on respiratory
August 13, 2021Theresa Flaherty, Managing Editor
INDIANAPOLIS – Apria Healthcare saw a healthy rebound in its oxygen and sleep business in the second quarter, and that’s where the company will focus future growth efforts, said CEO Dan Starck on a recent earnings call.
“Our new patient starts on oxygen remained elevated above historical run rates and new sleep patient volumes ran above pre-pandemic levels, while ventilation and negative pressure wound therapy were at or near pre-pandemic levels,” said Starck, who...
Apria results ‘ahead of expectations’
August 6, 2021HME News Staff
INDIANAPOLIS – Apria Healthcare reported net revenue of $286.3 million for the second quarter of 2021, up 6.4% compared to the same quarter in 2020.
It reported net income of $20.6 million, up 153.1%. Adjusted EBITDA was $64.4 million, up 15.5%; and adjusted EBITDA less patient equipment capex was $44.1 million, up 2.2%.
“We delivered another strong quarter as our second quarter 2021 financial results were ahead of our expectations on all three of our key metrics, achieving...
Apria readies to move on
May 21, 2021Theresa Flaherty, Managing Editor
INDIANAPOLIS – Apria is readying itself for a post-COVID world by embracing flexible working arrangements and leveraging telehealth to meet patients where they are, says CEO Dan Starck.
While most of its patient-facing staff and operations remained working onsite throughout the pandemic and others who had transitioned to the home are slowly moving back to the office, the company is committed to a hybrid model going forward, he says.
“The pandemic challenged all of us to rapidly...